Addyi Joins Stronvivo

HOUSTON–With the FDA’s approval of the once-a-day, prescription, Addyi, women suffering with the most common sexual dysfunction, decreased libido or hypoactive sexual desire disorder (HSDD), now have Addyi (Flibanserin), previously dubbed the “pink pill” and “female Viagra.” And, for women looking for a natural remedy or companion to Addyi, Stronvivo is available. Shown to increase blood flow and female sexual desire, Stronvivo is a valuable companion product for women who take Addyi. Until Addyi’s approval, Stronvivo was the only certified choice for women who wanted to boost their libido and enhance their sexual desire. Now, Addyi is available too.

Stronvivo is not a drug. It is an all-natural, Informed-Choice certified nutritional supplement comprised of USP-verified, pharmaceutical-grade ingredients including L-Arginine and L‐Citrulline, designed to restore, repair and rejuvenate the endothelium (the lining of the vast network of arteries, veins, and capillaries that make up our circulatory system) by stimulating nitric oxide production, relaxing smooth muscle tissue in the blood vessels, reducing platelet aggregation and adhesion, and improving circulation.

There are over 60,000 miles of endothelium cells in the body. One of the endothelium’sprimary functions to help regulate blood flow by producing nitric oxide, which relaxes the blood vessels and improves circulation throughout the body, delivering nutrients and oxygen to the brain, muscles, organs, and skin. When the body ages and nitric oxide levels fall, the heart is stressed, brain activity suffers and energy and libido decline. Poor circulation can impair sexual performance in both sexes, because the genitalia depend on a vigorous blood supply to achieve satisfaction.

Stronvivo, referred to as “Vitamins for blood vessels,” has been shown to improve female sexual desire, arousal, lubrication and orgasms, while reducing pain during intercourse.

“I’ve always been a passionate advocate for the 43 percent of women who suffer from sexual dysfunction,” said Michael L. Krychman, MD Executive Director of the Southern California Center for Sexual Health and Survivorship and sexual medicine gynecologist. “With so many brands competing for the consumer’s attention on TV and in the marketplace, my patients question what is best for them. Many factors like parenthood, low energy, self-esteem, stress and hostility can plague sexual health and intimacy and need to be addressed in an integrative approach. With Stronvivo, nitric oxide production is restored and patients report feeling more alert, energetic, less stressed and more interested in healthy sex. Women have also reported increased sexual desire, better lubrication, arousal and orgasm, and men, stronger erections. Both men and women can take Stronvivo to improve heart health, vitality, energy and overall mood.”

While Addyi is approved by the FDA to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, Stronvivo can be used by pre and post menopausal women and is not intended to prevent, treat, cure or diagnose any disease. The FDA has not evaluated these statements.